JP2019524814A5 - - Google Patents
Info
- Publication number
- JP2019524814A5 JP2019524814A5 JP2019507271A JP2019507271A JP2019524814A5 JP 2019524814 A5 JP2019524814 A5 JP 2019524814A5 JP 2019507271 A JP2019507271 A JP 2019507271A JP 2019507271 A JP2019507271 A JP 2019507271A JP 2019524814 A5 JP2019524814 A5 JP 2019524814A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- disease
- alkyl
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662374657P | 2016-08-12 | 2016-08-12 | |
| US62/374,657 | 2016-08-12 | ||
| PCT/US2017/046807 WO2018032012A1 (en) | 2016-08-12 | 2017-08-14 | Amide compounds, pharmaceutical compositions thereof, and methods of using the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019524814A JP2019524814A (ja) | 2019-09-05 |
| JP2019524814A5 true JP2019524814A5 (enExample) | 2022-08-01 |
| JP7140748B2 JP7140748B2 (ja) | 2022-09-21 |
Family
ID=61163345
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019507271A Active JP7140748B2 (ja) | 2016-08-12 | 2017-08-14 | アミド化合物、その医薬組成物、及びその使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11325886B2 (enExample) |
| EP (1) | EP3497077A4 (enExample) |
| JP (1) | JP7140748B2 (enExample) |
| KR (1) | KR102537274B1 (enExample) |
| CN (1) | CN109843849B (enExample) |
| AU (1) | AU2017310535B2 (enExample) |
| IL (1) | IL264765B2 (enExample) |
| MX (1) | MX394123B (enExample) |
| RU (1) | RU2759913C2 (enExample) |
| WO (1) | WO2018032012A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020008498A (es) * | 2018-02-14 | 2020-09-25 | Univ Oregon Health & Science | Derivados de sobetirome. |
| EP3894383A1 (en) * | 2018-12-12 | 2021-10-20 | Autobahn Therapeutics, Inc. | Novel thyromimetics |
| CN119431265A (zh) * | 2019-02-21 | 2025-02-14 | 南京瑞捷医药科技有限公司 | 一种作为甲状腺激素受体激动剂的化合物 |
| CA3130371A1 (en) * | 2019-03-01 | 2020-09-10 | Autobahn Therapeutics, Inc. | Novel thyromimetics |
| CN115279359A (zh) | 2019-11-29 | 2022-11-01 | 速通医疗公司 | 新型拟甲状腺素药 |
| EP4168384A4 (en) | 2020-06-17 | 2024-07-10 | Autobahn Therapeutics, Inc. | THYROMIMETICS |
| EP4167986A4 (en) * | 2020-06-17 | 2024-11-20 | Autobahn Therapeutics, Inc. | THYROMIMETICS |
| AU2022271304A1 (en) | 2021-05-06 | 2023-11-23 | Autobahn Therapeutics, Inc. | Fatty acid amide hydrolase (faah) cleavable prodrugs of thyromimetics and combination with peripherally restricted faah inhibitors |
| WO2023177667A1 (en) * | 2022-03-16 | 2023-09-21 | Brii Biosciences, Inc. | Thyroid hormone receptor agonists |
| WO2025019825A2 (en) * | 2023-07-20 | 2025-01-23 | Brii Biosciences, Inc. | Substituted 2-(3,5-dichloro-4-(4-hydroxy-benzyl)phenoxy)acetamide derivatives |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4320444A1 (de) * | 1993-06-21 | 1994-12-22 | Agfa Gevaert Ag | Farbfotografisches Aufzeichnungsmaterial |
| US5883294A (en) * | 1997-06-18 | 1999-03-16 | The Regeants Of The University Of California | Selective thyroid hormone analogs |
| GB9828442D0 (en) * | 1998-12-24 | 1999-02-17 | Karobio Ab | Novel thyroid receptor ligands and method II |
| US6436990B1 (en) | 1999-10-27 | 2002-08-20 | Nobex Corporation | 6-methoxy-2-naphthylacetic acid prodrugs |
| US6429223B1 (en) | 2000-06-23 | 2002-08-06 | Medinox, Inc. | Modified forms of pharmacologically active agents and uses therefor |
| US20090232879A1 (en) | 2005-05-26 | 2009-09-17 | Metabasis Therapeutics, Inc. | Thyromimetics for the Treatment of Fatty Liver Diseases |
| RU2007148927A (ru) * | 2005-05-26 | 2009-07-10 | Метабэйзис Терапьютикс, Инк. (Us) | Новые тиреомиметики, содержащие фосфиновую кислоту |
| CN101180097A (zh) | 2005-05-26 | 2008-05-14 | 症变治疗公司 | 新型含次膦酸的拟甲状腺素药 |
| GB0608724D0 (en) * | 2006-05-03 | 2006-06-14 | Karobio Ab | Novel Pharmaceutical Compositions |
| WO2014178892A1 (en) | 2013-05-03 | 2014-11-06 | Scanlan Thomas S | Use of sobetirome in the treatment of x-linked adrenolenoleukodystrophy |
| PE20180021A1 (es) * | 2015-02-20 | 2018-01-09 | Univ Oregon Health & Science | Derivados de sobetiroma |
-
2017
- 2017-08-14 US US16/325,096 patent/US11325886B2/en active Active
- 2017-08-14 WO PCT/US2017/046807 patent/WO2018032012A1/en not_active Ceased
- 2017-08-14 IL IL264765A patent/IL264765B2/en unknown
- 2017-08-14 AU AU2017310535A patent/AU2017310535B2/en active Active
- 2017-08-14 KR KR1020197007219A patent/KR102537274B1/ko active Active
- 2017-08-14 EP EP17840413.3A patent/EP3497077A4/en active Pending
- 2017-08-14 CN CN201780063087.9A patent/CN109843849B/zh active Active
- 2017-08-14 MX MX2019001634A patent/MX394123B/es unknown
- 2017-08-14 JP JP2019507271A patent/JP7140748B2/ja active Active
- 2017-08-14 RU RU2019106656A patent/RU2759913C2/ru active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2019106656A (ru) | Амидные соединения, содержащие их фармацевтические композиции и способы их применения | |
| JP2016510317A5 (enExample) | ||
| RU2018107227A (ru) | Терапевтические и профилактические антибактериальные средства | |
| US12251379B2 (en) | Methods of inhibiting formation of alpha synuclein aggregates | |
| RU2689984C2 (ru) | Лечение катаплексии | |
| JP2013523893A5 (enExample) | ||
| HRP20190500T1 (hr) | Farmaceutska kombinacija 3-(3-dimetilamino-1-etil-2-metil-propil)-fenola i pregabalina ili gabapentina | |
| JP2007517059A5 (enExample) | ||
| CA2798514A1 (en) | Heterocyclic sulfone mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction | |
| WO2007127137B1 (en) | Disubstituted aniline compounds | |
| JP2014520072A5 (enExample) | ||
| JP2016516074A5 (enExample) | ||
| JP2016508994A5 (enExample) | ||
| ME02390B (me) | Inhibitori beta sekretaze | |
| US20170100352A1 (en) | Methods for treating or preventing neuroinflammation or autoimmune diseases | |
| JP2015506982A5 (enExample) | ||
| RU2007101685A (ru) | Модуляторы никотиновых ацетилхолиновых рецепторов альфа 7 и их терапевтические применения | |
| MX2021007780A (es) | Composiciones y metodos para tratar trastornos neurodegenerativos. | |
| JP2022522334A5 (enExample) | ||
| JP2023530709A5 (enExample) | ||
| KR102714037B1 (ko) | 자가면역 질환 치료용 조성물 및 방법 | |
| JP2013538218A5 (enExample) | ||
| JP2022511730A5 (enExample) | ||
| CA2573413A1 (en) | Histone deacetylase inhibitors | |
| RU2017116230A (ru) | Конъюгаты и производные простагландина для лечения глаукомы и внутриглазной гипертензии |